LINC00152 is a potential biomarker involved in the modulation of biological characteristics of residual colorectal cancer cells following chemoradiotherapy

Concurrent radiotherapy and chemotherapy is a widely used, comprehensive treatment for rectal cancer. By studying the impact of concurrent chemoradiotherapy on the invasion and migration of colorectal cancer (CRC) cells and researching the associated molecular mechanisms, the present study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhengting, Cai, Xinyi, Chang, Li, Xia, Yaoxiong, Wang, Li, Hou, Yu, Li, Lan, Pan, Dingguo, Li, Furong, Liu, Shan, Xiong, Wei, Li, Wenhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835918/
https://www.ncbi.nlm.nih.gov/pubmed/29541183
http://dx.doi.org/10.3892/ol.2018.7833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835918/
https://www.ncbi.nlm.nih.gov/pubmed/29541183
http://dx.doi.org/10.3892/ol.2018.7833

Ejemplares similares